EZZ ezz life science holdings limited

If this growth rate was applied to FY24 revenue, it's more like...

  1. 2,062 Posts.
    lightbulb Created with Sketch. 504
    If this growth rate was applied to FY24 revenue, it's more like 140m. However I expect sales to be lumpy...more than doubling q3 and q4 will be challenging considering these were already at over 20m each quarter.
    Bottom line is also important. If they can maintain last years NPAT ratio and bring in revenue over 100m, the SP should be solidly above $5 which wouldn't be a stretch on the PE being around 20.

    Problem is, there is no reliability on revenue or profit ratio... Hence the low market cap. Also representative of the fact that it's a risky play with downside risks of them not growing profit.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.03
Change
0.000(0.00%)
Mkt cap ! $95.76M
Open High Low Value Volume
$2.10 $2.10 $2.03 $49.36K 23.80K

Buyers (Bids)

No. Vol. Price($)
3 3860 $2.03
 

Sellers (Offers)

Price($) Vol. No.
$2.12 462 1
View Market Depth
Last trade - 16.10pm 01/08/2025 (20 minute delay) ?
EZZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.